Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Zonisamide for Heavy Drinkers With Bipolar Disorder.

Next Previous
Trial Profile

Zonisamide for Heavy Drinkers With Bipolar Disorder.

Status: Discontinued
Phase of Trial: Phase II

Latest Information Update: 17 Sep 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Zonisamide (Primary)
  • Indications Alcoholism; Bipolar disorders
  • Focus Biomarker; Therapeutic Use
  • Acronyms ZNS-BP

Most Recent Events

  • 13 Jul 2015 According to the ClinicalTrials.gov record, planned end date changed from 1 Sep 2015 to 1 Sep 2016.
  • 13 Jul 2015 According to the ClinicalTrials.gov record, planned primary completion date changed to 1 Apr 2016.
  • 19 Jun 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top